Cargando…
The MAPK pathway as an apoptosis enhancer in melanoma
Inhibition of RAF/MEK/ERK signaling is beneficial for many patients with BRAF(V600E)–mutated melanoma. However, primary and secondary resistances restrict long-lasting therapy success. Combination therapies are therefore urgently needed. Here, we evaluate the cellular effect of combining a MEK inhib...
Autores principales: | Haydn, Johannes M., Hufnagel, Anita, Grimm, Johannes, Maurus, Katja, Schartl, Manfred, Meierjohann, Svenja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148120/ https://www.ncbi.nlm.nih.gov/pubmed/24970815 |
Ejemplares similares
-
Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins
por: Teutschbein, Janka, et al.
Publicado: (2010) -
MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation
por: Meierjohann, Svenja, et al.
Publicado: (2010) -
BRAF inhibition causes resilience of melanoma cell lines by inducing the secretion of FGF1
por: Grimm, Johannes, et al.
Publicado: (2018) -
NRF2 Enables EGFR Signaling in Melanoma Cells
por: Kreß, Julia Katharina Charlotte, et al.
Publicado: (2021) -
Hypoxia-Independent Drivers of Melanoma Angiogenesis
por: Meierjohann, Svenja
Publicado: (2015)